Back
Spyre Therapeutics Stock Predictions
Sponsored
SYRE
Sponsored
Gold Set to Skyrocket as Fed Slashes Rates
Click here for the details on this incredible opportunity.
Buy
76
SYRE
Spyre Therapeutics
Last Price:
34.38
Seasonality Move:
10.02%
7 Day Trial
ALL ACCESS PASS
$
7
AI DIVIDENDS: No. 1 Way to Collect Passive Income
Click here to get it for free.Spyre Therapeutics Stock Forecast
- Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 11.9% based on the past 8 years of stock performance.
- Spyre Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Spyre Therapeutics Stock Undervalued?
The current Spyre Therapeutics [SYRE] share price is $33.80. The Score for SYRE is 76, which is 52% above its historic median score of 50, and infers lower risk than normal. - SYRE is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
Will Spyre Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Spyre Therapeutics has on average historically risen by 11.9% based on the past 8 years of stock performance.
Spyre Therapeutics Stock Rating
Buy
76
Spyre Therapeutics (SYRE)
is a Buy
Is Spyre Therapeutics overpriced?
- Spyre Therapeutics has risen higher in 4 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Spyre Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
spyre.com
52-Week Data
52-Week High:
47.97
52-Week Low:
8.43
Prediction Charts
Market Cap:
1.72B
Price in USD:
33.80
Volume:
311.98K
Beta:
2.54
Technical Analysis
SMA50:
29.22
SMA100:
28.59
SMA200:
30.56
52-Wk Change:
217.07%
Stock Predictions
-
Is Spyre Therapeutics stock public?
Yes, Spyre Therapeutics is a publicly traded company. -
What is the Spyre Therapeutics stock quote today?
The Spyre Therapeutics stock price is 33.80 USD today. -
How to buy Spyre Therapeutics stock online?
You can buy Spyre Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-9 | 27.85 | 27.50 | 28.30 | 26.75 |
Oct-10 | 27.01 | 27.22 | 27.34 | 26.28 |
Oct-11 | 27.21 | 28.70 | 28.96 | 27.15 |
Oct-14 | 28.41 | 30.66 | 30.70 | 28.30 |
Oct-15 | 31.21 | 31.48 | 32.00 | 29.80 |
Oct-16 | 31.00 | 32.37 | 32.45 | 30.61 |
Oct-18 | 32.75 | 32.76 | 33.27 | 31.89 |
Oct-21 | 32.67 | 32.43 | 33.14 | 31.70 |
Oct-22 | 32.26 | 34.15 | 34.21 | 32.19 |
Oct-23 | 34.00 | 33.61 | 34.70 | 32.22 |
Oct-24 | 33.86 | 33.70 | 34.46 | 33.37 |
Oct-25 | 34.94 | 34.81 | 36.60 | 34.14 |
Oct-28 | 35.49 | 34.40 | 36.09 | 34.29 |
Oct-29 | 34.30 | 33.80 | 34.70 | 32.91 |
Spyre Therapeutics Earnings
Spyre Therapeutics Earnings Report: Per Share Spyre Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Spyre Therapeutics Forecast Revenue Growth
Spyre Therapeutics Stock Analysis: Historical quarterly revenues per share for Spyre Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.01 per share, and a decrease next year of $0.09 per share.
* Spyre Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.